ScholarIQanswers from OpenAlex

Epilepsy subtype-specific copy number burden observed in a genome-wide study of 17 458 subjects

PaperCitations, authors & open-access status

Epilepsy subtype-specific copy number burden observed in a genome-wide study of 17 458 subjects is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Epilepsy subtype-specific copy number burden observed in a genome-wide study of 17 458 subjects have?

ScholarIQcitation count

Epilepsy subtype-specific copy number burden observed in a genome-wide study of 17 458 subjects has 81 citations in the OpenAlex counts ScholarIQ stores.

When was Epilepsy subtype-specific copy number burden observed in a genome-wide study of 17 458 subjects published?

ScholarIQyear

Epilepsy subtype-specific copy number burden observed in a genome-wide study of 17 458 subjects has 2020 year in the ScholarIQ index.

What is the open-access status of Epilepsy subtype-specific copy number burden observed in a genome-wide study of 17 458 subjects?

ScholarIQoa status

Epilepsy subtype-specific copy number burden observed in a genome-wide study of 17 458 subjects has bronze oa status in the ScholarIQ index.

What is the DOI of Epilepsy subtype-specific copy number burden observed in a genome-wide study of 17 458 subjects?

ScholarIQdoi

The DOI for Epilepsy subtype-specific copy number burden observed in a genome-wide study of 17 458 subjects is on the source record.

What is the PMID of Epilepsy subtype-specific copy number burden observed in a genome-wide study of 17 458 subjects?

ScholarIQpmid

The PMID for Epilepsy subtype-specific copy number burden observed in a genome-wide study of 17 458 subjects is on the source record.

What is the OpenAlex record for Epilepsy subtype-specific copy number burden observed in a genome-wide study of 17 458 subjects?

ScholarIQopenalex

The OpenAlex for Epilepsy subtype-specific copy number burden observed in a genome-wide study of 17 458 subjects is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial